New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
Hosted on MSN1mon
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients"Typically, patients treated with systemic therapy for locally advanced hepatocellular carcinoma recur within ... referred to as macrovascular invasion (MVI), is associated with increased risk ...
Announcing a new publication for Acta Materia Medica journal. Epithelial cell adhesion molecule (EpCAM) is a biomarker for epithelial cell-derived tumors. However, the specific role of EpCAM itself in ...
A new prognostic model could potentially predict and stratify the risk for hepatocellular carcinoma (HCC) among patients with chronic hepatitis B (CHB) who are noncirrhotic and not indicated for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback